- <![CDATA[OncLive Polls Reveal Picks for Top GI Cancer Abstracts, Areas of Interest at ASCO 2026]]><![CDATA[Polls highlighted key abstracts of interest from the upcoming ASCO Annual Meeting.]]>onclive · 2mo ago↗ source
- M&A isn’t just for big pharma. Mid-size companies are stepping up deal huntsIn what is shaping up to be one of the most active years for biopharma M&A on record, a different-looking set of buyers is going shopping. Mid-cap American drugmakers, family-owned pharma gro…Endpoints · 2mo ago↗ source
- <![CDATA[Prevention and Personalization Drive the Future of Oncodermatology in Melanoma ]]><![CDATA[Beth McLellan, MD, discusses radiation dermatitis prevention, scalp cooling equity, and the future of personalized oncodermatology in melanoma management.]]>